How Are Incremental Cost-Effectiveness, Contextual Considerations, and Other Bene fits Viewed in Health Technology Assessment Recommendations in the United States?

摘要

Objectives: To review assessments from the Institute for Clinical and Economic Review (ICER) and describe how costeffectiveness, other benefits or disadvantages, and contextual considerations affect Council members' assessments of value.